FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

41125711000001106: Terbinafine 250mg tablets (Crescent Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2459871000001114 Terbinafine 250mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2459881000001111 Terbinafine 250mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terbinafine 250mg tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Is a Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terbinafine true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Has specific active ingredient Terbinafine hydrochloride true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Terbinafine 250mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Terbinafine 250mg tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start